From the world renowned Fred Hutchinson Cancer Research Center, this book is written for all physicians who treat patients with acute or chronic leukemias or myelodysplasia. It is designed to answer questions about treatment approaches that commonly arise in day-to-day practice. In keeping with the Center's groundbreaking research in bone marrow transplantation, the book provides exceptional coverage of the role of allogeneic transplant in treatment. It also addresses the important issues of supportive care and long-term complications of successful treatment.

•Edited and written by experts at the Fred Hutchinson Cancer Research Center
•Clinically focused and comprehensive coverage of treatment approaches
•Allogeneic transplant addressed in detail
•Separate chapters on supportive care and long-term complications

Edited and written by experts at the Fred Hutchinson Cancer Research Center Clinically focused and comprehensive coverage of treatment approaches Allogeneic transplant addressed in detail Separate chapters on supportive care and long-term complications

Autorentext
Elihu H. Estey, M.D.Professor of MedicineDivision of HematologyUniversity of Washington School of MedicineMember, Fred Hutchinson Cancer Research Center Attending Physician, Seattle Cancer Care AllianceSeattle, WA USAFrederick R. Appelbaum, MD Professor of MedicineHead, Division of OncologyDirector, Clinical Research Division, Fred Hutchinson Cancer Research CenterExecutive Director, Seattle Cancer Care AllianceUniversity of Washington School of MedicineSeattle, WA USA

Inhalt

1. Acute Myeloid Leukemia (AML).- 2. The Treatment of Adult Acute Lymphoblastic Leukemia (ALL): Risk Stratification and Strategies.- 3. Chronic Lymphocytic Leukemia (CLL).- 4. Chronic Myelogenous Leukemia (CML).- 5. Myelodysplastic Syndromes (MDS).- 6. Myeloablative transplant (HCT).- 7. Reduced-intensity and Non-Myeloablative Conditioning Followed by Hematopoietic Cell Transplantation.- 8. Alternative Donor Hematopoietic Stem Cell Transplantation A Role for Umbilical Cord Blood Transplantation for Hematologic Malignancies.- 9. The Detection and Significance of Minimal Residual Disease.- 10. Late Effects after Treatment for Leukemia.- 11. Transfusion Support of the Patient with Hematologic Malignancy.- 12. Infections in Leukemia and Hematopoietic Stem Cell Transplantation.